PharmiWeb44m
Drägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend
Annual Report/DividendDrägerwerk AG & Co. KGaA: Dräger increases net profit in fiscal year 2024 and raises dividend 31.03.2025 / 07:30 CET/CESTThe issuer is solely responsible for the content of this ...
PharmiWeb1h
AEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025
Annual ResultsAEVIS VICTORIA SA - Infracore strengthens its balance sheet and prepares for accelerated growth in 2025 31.03.2025 / 07:00 CET/CESTPress releaseFribourg, 31 March 2025Infracore ...
PharmiWeb1h
Biotest AG increases sales by 6% in financial year 2024
Annual ReportBiotest AG increases sales by 6% in financial year 2024 31.03.2025 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.  PRESS RELEASE  Biotest AG ...
PharmiWeb1h
BIOVERSYS ANNOUNCES IMPORTANT BV100 PATENT GRANTED BY CHINESE PATENT OFFICE
CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LRBasel, Switzerland.
PharmiWeb19h
DEA Forces Marijuana Pharma Drug Industry Offshore: A Symbol of DEA Systemic Obstruction Against Trump Administration Directives
"The DEA's marijuana approach is stuck in an outdated ‘war on drugs' mentality," said Duane Boise CEO of MMJ International Holdings. "While lawmakers push for medical progress, the DEA's red tape is ...
PharmiWeb1d
CPC Announces Semaglutide Significantly Improves Walking Distance, Symptoms and Quality of Life for People with PAD and Diabetes
Study underscores the direct vascular effects of this class of drugs, researchers say AURORA, CO / ACCESS Newswire / March 29, 2025 / A novel study of a semaglutide, a glucagon-like peptide-1 (GLP-1) ...
PharmiWeb2d
Lifeloc Technologies Reports 2024 Full Year Results
WHEAT RIDGE, CO / ACCESS Newswire / March 28, 2025 / Lifeloc Technologies, Inc. (OTC PINK:LCTC), a global leader in the ...
PharmiWeb2d
Solaxa Announces Phase 3 Clinical Trial for Spinocerebellar Ataxia Type 27B
BETHESDA, MARYLAND / ACCESS Newswire / March 28, 2025 / Solaxa Inc., a biopharmaceutical public benefit corporation focused on rare neurological conditions, has announced plans to conduct a ...
PharmiWeb2d
PointClickCare and VistaRx Announce Joint Solution That Solves Incorrect Billing in Long-Term Care
SALT LAKE CITY, UTAH / ACCESS Newswire / March 28, 2025 / PointClickCare, a leading healthcare technology platform enabling meaningful collaboration across the care continuum, and VistaRx, a ...
PharmiWeb2d
Global Healthcare Faces Unprecedented Cybersecurity Crisis: Black Book Research Reveals Top 10 Countries at Highest Risk
LONDON, GB / ACCESS Newswire / March 28, 2025 / Black Book Market Research, a leading independent and unbiased technology ...
PharmiWeb2d
UniDoc Completes Purchase of AGNES Connect(R) Software from AMD Telemedicine
VANCOUVER, BC / ACCESS Newswire / March 28, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), announces that, further to its news release dated March 19, 2025, ...
PharmiWeb2d
The Future of Physical Therapy: Trends to Watch in 2025 and Beyond
Find out the change in Physiotherapy DUBAI, UAE / ACCESS Newswire / March 28, 2025 / Since the immerge of healthcare innovation and technology, there has been significant change that's complementing ...